 | IAVI, Merck KGaA, Serum Institute join hands to develop monoclonal antibodies for COVID-19Under IAVI's agreement with Merck KGaA and Serum Institute, the partners will conduct an accelerated, integrated program of preclinical and clinical research to evaluate the antibodies. |
 | If everything goes well India would get COVID-19 vaccine by year-end: Harsh VardhanThree COVID-19 vaccine candidates, including two indigenous ones, are in different phases of development in India. |
